Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study Phase C: Expansion Into Multiple Institutions for Training in the Use of the LUM Imaging System for Intraoperative Detection of Residual Cancer in the Tumor Bed of Female Subjects With Breast Cancer

NCT03321929 is registered in ClinicalTrials.gov with Lumicell, Inc. as lead sponsor.

NCT NCT03321929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03321929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study Phase C: Expansion Into Multiple Institutions for Training in the Use of the LUM Imaging System for Intraoperative Detection of Residual Cancer in the Tumor Bed of Female Subjects With Breast Cancer
Lead sponsor
Lumicell, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 6, 2018
Completion date
April 10, 2020
Enrollment
234 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer